KIAA0174 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.970600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.397180E-01
Normal-vs-Stage2
3.294400E-01
Normal-vs-Stage3
1.197000E-01
Normal-vs-Stage4
9.009400E-01
Stage1-vs-Stage2
7.018000E-01
Stage1-vs-Stage3
2.524200E-01
Stage1-vs-Stage4
1.229590E-01
Stage2-vs-Stage3
1.005980E-01
Stage2-vs-Stage4
2.021000E-01
Stage3-vs-Stage4
8.718100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.817800E-01
Normal-vs-AfricanAmerican
2.767200E-01
Normal-vs-Asian
3.765800E-01
Caucasian-vs-AfricanAmerican
9.711000E-01
Caucasian-vs-Asian
8.474200E-01
AfricanAmerican-vs-Asian
8.930200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.163600E-01
Normal-vs-Female
2.856600E-01
Male-vs-Female
8.380600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.328400E-01
Normal-vs-Age(41-60Yrs)
4.738000E-01
Normal-vs-Age(61-80Yrs)
2.454200E-01
Normal-vs-Age(81-100Yrs)
1.962760E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.447000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.111200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.630800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.797800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.072000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.295600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.117360E-01
Normal-vs-Daily Drinker
2.914400E-01
Normal-vs-Weekly Drinker
1.191590E-01
Normal-vs-Occasional Drinker
8.127200E-01
Normal-vs-Social Drinker
2.569000E-01
Non Drinker-vs-Daily Drinker
3.541600E-01
Non Drinker-vs-Weekly Drinker
8.212000E-01
Non Drinker-vs-Occasional Drinker
3.062600E-03
Non Drinker-vs-Social Drinker
2.307400E-01
Daily Drinker-vs-Weekly Drinker
3.456000E-01
Daily Drinker-vs-Occasional Drinker
6.006300E-02
Daily Drinker-vs-Social Drinker
7.818000E-01
Weekly Drinker-vs-Occasional Drinker
6.261700E-03
Weekly Drinker-vs-Social Drinker
2.171800E-01
Occasional Drinker-vs-Social Drinker
8.581700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.002400E-02
Normal-vs-Grade 2
2.015800E-04
Normal-vs-Grade 3
8.391400E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.980400E-02
Grade 1-vs-Grade 3
1.988340E-02
Grade 1-vs-Grade 4
4.002400E-02
Grade 2-vs-Grade 3
3.535200E-01
Grade 2-vs-Grade 4
2.015800E-04
Grade 3-vs-Grade 4
8.391400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.897210E-01
Normal-vs-NonDiabetic
3.056000E-01
Diabetic-vs-NonDiabetic
3.270000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.271000E-01
Normal-vs-NoPancreatitis
2.489000E-01
Pancreatitis-vs-NoPancreatitis
2.955000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.881000E-01
Normal-vs-N1
3.240600E-01
N0-vs-N1
7.788200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.674800E-01
Normal-vs-TP53-NonMutant
1.900760E-01
TP53-Mutant-vs-TP53-NonMutant
1.229320E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
